1
Clinical Trials associated with ACIT-1 cancer vaccine(Institute for Cancer Vaccines & Immunotherapy)A Phase I Clinical Study to Determine the Optimal Dose for the Safe Immune Restoration and Immune Response of Allogeneic Cell Immunotherapy (ACIT-1) in Adult Cancer Patients
This study evaluates four different doses of ACIT-1 for safety and for the ability to raise effective anti-cancer immune responses in patients with pancreatic and other cancers. Approximately half of the patients will have pancreatic cancer and the other half will have other cancers.
100 Clinical Results associated with ACIT-1 cancer vaccine(Institute for Cancer Vaccines & Immunotherapy)
100 Translational Medicine associated with ACIT-1 cancer vaccine(Institute for Cancer Vaccines & Immunotherapy)
100 Patents (Medical) associated with ACIT-1 cancer vaccine(Institute for Cancer Vaccines & Immunotherapy)
100 Deals associated with ACIT-1 cancer vaccine(Institute for Cancer Vaccines & Immunotherapy)